Xvivo Perfusion AB (publ) (0RKL.L)

SEK 461.69

(1.25%)

Net Debt Summary of Xvivo Perfusion AB (publ)

  • Xvivo Perfusion AB (publ)'s latest annual net debt in 2023 was -214.65 Million SEK , up 9.25% from previous year.
  • Xvivo Perfusion AB (publ)'s latest quarterly net debt in 2024 Q3 was -440.14 Million SEK , up 2.95% from previous quarter.
  • Xvivo Perfusion AB (publ) reported annual net debt of -236.54 Million SEK in 2022, up 39.81% from previous year.
  • Xvivo Perfusion AB (publ) reported annual net debt of -392.97 Million SEK in 2021, down -13.5% from previous year.
  • Xvivo Perfusion AB (publ) reported quarterly net debt of -480.24 Million SEK for 2024 Q1, down -123.73% from previous quarter.
  • Xvivo Perfusion AB (publ) reported quarterly net debt of -463.64 Million SEK for 2024 Q2, up 3.46% from previous quarter.

Annual Net Debt Chart of Xvivo Perfusion AB (publ) (2023 - 2012)

Historical Annual Net Debt of Xvivo Perfusion AB (publ) (2023 - 2012)

Year Net Debt Net Debt Growth
2023 -214.65 Million SEK 9.25%
2022 -236.54 Million SEK 39.81%
2021 -392.97 Million SEK -13.5%
2020 -346.22 Million SEK -125.41%
2019 -153.59 Million SEK 17.54%
2018 -186.26 Million SEK 4.49%
2017 -195.02 Million SEK -734.46%
2016 -23.37 Million SEK 43.04%
2015 -41.03 Million SEK 14.87%
2014 -48.2 Million SEK -2006.76%
2013 2.52 Million SEK 92.54%
2012 1.31 Million SEK 0.0%

Peer Net Debt Comparison of Xvivo Perfusion AB (publ)

Name Net Debt Net Debt Difference